Migration and displacement can interrupt epilepsy care even when there is no immediate medical emergency. A person may cross a border with stable epilepsy, a known diagnosis and a treatment plan that has worked for years — and then discover that their medicine has a different brand name, their prescription is not recognised, their records are unavailable, their new health system uses different referral rules, or specialist care requires registration they have not yet completed.
For epilepsy, continuity matters because treatment is often long term and interruption can have immediate consequences. Missed antiseizure medicine doses can lead to breakthrough seizures, injury, seizure clusters or status epilepticus in susceptible people. Yet the barriers faced by refugees, asylum seekers and other migrants are often administrative, linguistic and structural rather than purely medical.
This page focuses on what happens when epilepsy care has to move with the person.
Migration does not end a chronic neurological condition
People move for many reasons: conflict, persecution, work, study, family reunion, poverty, climate pressures or personal choice. Some journeys are planned and documented. Others happen suddenly with very little time to prepare.
The underlying epilepsy continues regardless of why the person moved. Medicines still need to be taken, rescue plans still need to work, and specialist follow-up may still be necessary.
The central challenge is therefore continuity across changing health systems.
WHO treats continuity of care as a core migrant-health issue
The World Health Organization states that refugees and migrants should have equitable access to high-quality healthcare, essential medicines and financial protection regardless of migration status. WHO also specifically highlights good record keeping and cross-border continuity of care as important parts of migrant health.
This matters for epilepsy because fragmented care can easily lead to duplicate investigations, inappropriate medication changes or complete treatment interruption.
The first problem may be proving the treatment history
People arriving in a new country may have paper records, digital records, photographs of prescriptions or nothing at all. Documents may be written in another language or use unfamiliar abbreviations.
Even when the patient knows the medicine name, they may not remember the exact dose, formulation or timing. Brand names can differ substantially between countries, while the same brand name can occasionally refer to different products in different markets.
Clinicians therefore need to reconstruct the treatment history carefully rather than assume that unfamiliar packaging means unfamiliar treatment.
Generic names are safer across borders
International non-proprietary names and generic medicine names are generally more useful than brand names when care crosses national borders.
For example, a patient who knows only a local trade name may struggle to explain their treatment in another country, while knowing the active ingredient makes it much easier for clinicians and pharmacists to identify an equivalent product.
For long-term conditions such as epilepsy, keeping a written list of generic medicine names, doses and formulations can make transitions safer.
Formulation matters as much as the drug name
Modified-release, extended-release and immediate-release formulations are not automatically interchangeable in the same dosing schedule. Likewise, liquid concentrations can differ and paediatric dosing may depend on weight.
When treatment is transferred between countries, the important question is not merely whether the same active ingredient exists. The formulation, dose strength and timing must also be checked.
This is especially important for antiseizure medicines where stable blood levels may contribute to seizure control.
Prescription rules differ between countries
A prescription issued in one country may not be valid in another. Some antiseizure medicines are subject to different prescribing, dispensing or controlled-drug rules depending on jurisdiction.
A person may therefore arrive with only a limited supply and discover that they need to register with a new doctor before a replacement can legally be issued.
This administrative delay can become clinically important if the remaining supply is small.
Waiting for registration can create a treatment gap
New arrivals may need proof of address, identity documents, insurance registration or immigration paperwork before they understand how to enter the health system.
Even where emergency or primary care is legally available, patients may not know which service to contact. Fear of cost or uncertainty about entitlement can delay care further.
WHO emphasises that restrictive environments, institutional barriers and language difficulties can worsen health outcomes for migrant populations. For epilepsy, those barriers can translate directly into missed medicine doses and loss of specialist follow-up.
Irregular migration status can deter people from seeking care
Some migrants fear that contact with public services could affect immigration proceedings, trigger costs they cannot afford or expose them to authorities.
Even where those fears are not legally justified, perception alone can discourage people from registering with health services.
A person may therefore ration medicine or wait until seizures worsen before seeking help.
Access should not depend on whether a person understands the health system
Health systems are complex even for people who have lived in them all their lives. For a newly arrived person, the distinction between primary care, emergency care, neurology, pharmacy and specialist epilepsy services may be completely unfamiliar.
Migrant-sensitive services need clear navigation, interpretation and information about how to obtain repeat prescriptions, urgent care and specialist referral.
This is a systems responsibility, not simply an individual communication problem.
Language barriers can alter medication safety
Epilepsy care involves details that are easy to lose in translation: seizure type, frequency, duration, warning symptoms, rescue medication instructions, pregnancy risks, missed-dose advice and previous adverse effects.
Professional interpretation is therefore preferable to relying solely on family members, particularly children, for complex consultations.
Written instructions should ideally be available in a language the patient understands, with generic drug names and clear dose schedules.
Trust affects adherence and follow-up
Research involving foreign-born people with epilepsy has found that trustful communication and reliable access to health consultations are important to feeling safe in care. Migration-related social pressures, reduced support networks and multiple competing problems can overshadow epilepsy and contribute to missed appointments or apparent non-adherence.
Clinicians should therefore avoid assuming that missed appointments or medication problems reflect indifference to treatment. Housing instability, transport, employment, childcare and immigration appointments can all affect continuity.
Social conditions can become seizure-care conditions
Housing, employment, income and legal status can indirectly influence seizure control. A person living in unstable accommodation may have nowhere secure to store medicines. Someone working irregular hours may struggle with consistent dosing and sleep.
People awaiting asylum decisions may move between accommodation sites with little notice. Each move can interrupt registration with local services.
For epilepsy, social determinants and medical continuity are therefore tightly connected.
Refugees and asylum seekers may move several times
Displacement is rarely a single journey from one stable system to another. A person may move from their home region to a transit country, then to a reception centre, temporary accommodation and eventually permanent resettlement.
Each move creates another opportunity for records, prescriptions and specialist referrals to be lost.
A robust continuity system needs to follow the person rather than remain tied to one clinic.
Repeated diagnostic work can result from fragmented records
If previous EEG, MRI and specialist letters cannot be accessed, a receiving neurologist may have to repeat investigations before making treatment decisions.
Sometimes repeating tests is clinically necessary. But unnecessary duplication wastes scarce resources and delays care.
Portable digital summaries and interoperable health records can therefore reduce both cost and uncertainty.
Imaging and EEG data are harder to transfer than prescriptions
A written report is useful, but epilepsy specialists may also want to review the original EEG traces or MRI images. These files can be large, stored in proprietary systems or inaccessible outside the original hospital network.
Cross-border care is much easier when patients can obtain copies of key imaging and neurophysiology data in transferable formats.
For people being considered for epilepsy surgery, loss of original presurgical data can be especially disruptive.
Different countries may classify seizures differently in practice
Modern international classification systems are widely used, but local terminology and documentation can vary. Older labels may still appear in medical records.
A receiving clinician may therefore need to reinterpret previous descriptions rather than rely entirely on the original label.
Detailed descriptions of what actually happens during seizures can be more valuable than terminology alone.
Medicine availability varies between countries
A medicine that is routinely prescribed in one country may be unavailable, expensive or restricted in another. Conversely, a receiving health system may prefer a different first-line medicine because of local formularies, cost or prescribing guidelines.
This can force a treatment change even when the previous regimen worked well.
Where possible, stable treatment should not be altered casually. If change is necessary, it should be planned rather than triggered by sudden stock depletion.
WHO still identifies medicine availability as a global epilepsy problem
WHO reports that in many low- and middle-income countries, availability of generic antiseizure medicines in the public sector remains limited. This means migration can move a person either into or out of reliable medicine access depending on the direction of travel.
Continuity problems are therefore not one-way. A person leaving a well-supplied system may struggle to obtain the same treatment elsewhere, while another person may gain access after relocation.
Cost can change overnight
Patients may move from a publicly funded health system to one where consultations, prescriptions or medicines involve direct payment. The reverse can also occur.
A treatment that was previously affordable may suddenly become financially unsustainable.
This can lead to rationing, dose skipping or substitution without clinical advice.
Cross-border medicine access has been tested in recent refugee crises
The large-scale displacement from Ukraine prompted European health systems to develop practical mechanisms for continuity of medicines and chronic disease care. Research examining this response highlighted both the feasibility of inclusive access and the longstanding barriers experienced by other migrant groups.
The lesson is broader than one conflict: systems can simplify access when continuity is treated as a health priority.
Arrival care should include chronic disease continuity
Initial migrant or refugee health assessments often focus on infectious disease, vaccination, pregnancy and immediate physical health. Chronic neurological conditions can be overlooked if the patient appears clinically stable.
For epilepsy, early questions about medication supply, recent seizures, rescue medicines and previous specialist follow-up can prevent later emergencies.
The goal is not compulsory neurological screening, but recognition of established conditions that require uninterrupted care.
WHO does not support compulsory migrant health screening
WHO states that there is no clear evidence supporting compulsory disease screening for refugees and migrants on arrival and warns that such practices can deter people from seeking healthcare.
Voluntary, accessible and non-discriminatory care is preferable.
This principle matters because people with epilepsy should not feel that disclosing a diagnosis threatens immigration status or freedom of movement.
Children can lose both medical and educational continuity
A child with epilepsy who moves country may lose a paediatric neurologist, school care plan, rescue medication protocol and classroom support simultaneously.
Parents may need to explain the seizure pattern from the beginning to new clinicians and new school staff.
Where epilepsy coexists with learning disability, autism or developmental problems, the disruption can be even greater.
School seizure plans may not transfer automatically
Education systems differ in whether school staff can administer rescue medication, what documentation is required and how health plans are written.
A child who was previously supported safely at school may therefore face delays before equivalent arrangements are put in place.
Medical continuity should include practical school information where relevant.
Pregnancy and reproductive care require special continuity
People who can become pregnant may need counselling about medicine risks, contraception interactions, folic acid and pregnancy planning.
Moving between countries can interrupt these discussions or lead to sudden substitution of antiseizure medicines without awareness of reproductive safety considerations.
Pregnant migrants with epilepsy need access to both obstetric and neurological care rather than being managed in isolation by one service.
Valproate restrictions may differ by jurisdiction
Regulatory rules concerning valproate, pregnancy prevention and reproductive risk vary internationally. A person who moves country may encounter different prescribing restrictions, consent processes or monitoring requirements.
The underlying fetal risks do not change at the border, but the legal and regulatory framework can.
Receiving clinicians therefore need to review reproductive safety rather than simply renew a previous prescription without context.
Driving rules can change after migration
Driving regulations for epilepsy differ between countries. A licence valid in one jurisdiction may not remain valid after relocation, and seizure-free periods required for licensing vary.
Patients need local advice rather than assuming previous rules continue to apply.
This can affect employment, independence and family finances even when seizure control itself has not changed.
Employment and disclosure rules also differ
Legal protections against disability discrimination vary internationally, as do occupational restrictions for safety-critical work.
A migrant may therefore move from a job they were permitted to do into a jurisdiction where different medical standards apply — or vice versa.
Epilepsy continuity includes social and legal continuity as well as medication.
Rescue medicines can be especially difficult to transfer
Products used for prolonged seizures may differ in formulation and availability between countries. Buccal, intranasal and rectal preparations may not all be licensed or routinely supplied everywhere.
Families who rely on a specific rescue plan need a locally workable replacement if the usual product is unavailable.
Written instructions should be updated rather than assuming emergency responders will recognise an overseas brand.
Specialist referrals may restart from the beginning
A patient previously under tertiary epilepsy care may enter a new country through primary care and have to progress through the entire referral pathway again.
Waiting lists can be especially problematic for people with drug-resistant epilepsy, pregnancy, frequent injuries or possible surgical candidacy.
Systems that recognise prior specialist documentation can reduce unnecessary delay.
Drug-resistant epilepsy should not disappear during relocation
If a person has already failed adequate trials of appropriate medicines, relocation should not reset their history to ‘try another few tablets first’ simply because the new team lacks records.
Where possible, previous medication failures, reasons for stopping and seizure outcomes should be reconstructed carefully.
This is particularly important for referral to epilepsy surgery services.
Mental health can affect continuity without replacing the epilepsy diagnosis
Migration and forced displacement can involve trauma, bereavement, isolation and uncertainty. Depression, anxiety and post-traumatic stress can coexist with epilepsy and may affect sleep, adherence and engagement with healthcare.
Functional or dissociative seizures can also occur in migrant and displaced populations, and can coexist with epileptic seizures.
Clinicians should avoid assuming that seizure recurrence in a traumatised person is automatically psychological.
Family networks may shrink after migration
A person who previously relied on extended family for transport, supervision after seizures or medication reminders may arrive in a country with only one relative or none at all.
This can increase practical risk even if seizure frequency remains unchanged.
Support needs should therefore be reassessed after relocation rather than assuming the old care environment still exists.
Cultural explanations of epilepsy may differ
People may come from communities where epilepsy is understood through spiritual, supernatural or traditional frameworks. These beliefs can coexist with biomedical treatment rather than simply replacing it.
Respectful communication helps clinicians understand what the patient believes, which treatments they are using and whether any practice could interfere with medication or safety.
Dismissive communication can damage trust and make continuity harder.
Stigma can cross borders too
Moving country does not necessarily remove epilepsy stigma. Some people may become more reluctant to disclose the diagnosis because they fear discrimination in housing, employment or immigration processes.
Others may experience less stigma after migration and become more willing to seek care.
The effect depends on both the origin community and the receiving environment.
Mainstream inclusion is better than permanent parallel care
WHO recommends that, beyond the acute emergency phase, refugees and migrants should be integrated into ordinary national health systems rather than kept indefinitely in separate services.
For epilepsy, this means access to the same primary care, neurology, maternity, paediatric and emergency pathways as the host population.
Parallel charity clinics can provide important short-term support, but long-term continuity is more secure when responsibility is embedded in the health system itself.
Portable health information can reduce risk
Useful information includes diagnosis, seizure types, current medicines and doses, allergies, previous failed treatments, rescue medication, important EEG or MRI findings, pregnancy considerations and the contact details of the previous specialist team.
Digital summaries can help, but paper copies remain valuable where connectivity is unreliable.
The aim is not to make patients responsible for solving interoperability failures, but to provide another layer of protection.
What patients can reasonably carry
Where migration is planned, practical preparation can include an adequate legal medicine supply, a medication list using generic names, copies of key clinic letters and, when feasible, copies of imaging or EEG reports.
People should also check destination-country rules for carrying medicines across borders because requirements for documentation and controlled medicines vary.
In forced displacement, of course, this preparation may be impossible.
Health systems should design for mobility, not assume permanent residence
Global mobility is now a routine feature of modern healthcare. WHO estimated in 2026 that more than a billion people worldwide are on the move in some form, including hundreds of millions of international migrants and more than a hundred million forcibly displaced people.
Health services therefore need continuity mechanisms that work across regions and borders rather than treating migration as an exceptional event.
Better continuity benefits host health systems too
Reliable access to routine medication can prevent avoidable emergency visits, injuries and hospital admissions.
Good record transfer reduces unnecessary repeat investigations. Professional interpretation reduces medication errors. Early registration reduces crisis-driven use of emergency services.
Inclusive continuity is therefore not only a humanitarian principle; it is also efficient health-system design.
The central problem is fragmentation
A person can cross a border in a matter of hours, but their medical history does not automatically cross with them.
Epilepsy care fragments when prescriptions, records, specialists, insurance, language and legal entitlement all change at different speeds.
The clinical objective is simple even if the system problem is not: preserve the treatment that is working, identify what genuinely needs reassessment, and prevent administrative transition from becoming a neurological emergency.
What this page does — and does not — explain
This page focuses on migration, displacement and continuity of epilepsy care across health systems. Acute disruption during war, disaster and humanitarian emergencies is covered separately on Epilepsy Care in Humanitarian Emergencies and Conflict. Global medicine availability is covered in the separate Access to Antiseizure Medicines Worldwide page.
Sources
World Health Organization — Refugee and migrant health
WHO — Refugee and migrant health: questions and answers
Trustful communication in the medical encounter: perspectives of immigrated people with epilepsy
Facilitating access to medicines and continuity of care for Ukrainian refugees
Epilepsy and psychogenic non-epileptic seizures in forcibly displaced people
Treating epilepsy in forcibly displaced persons
Neurological care priorities for refugees and other forcibly displaced people
WHO — Epilepsy fact sheet
Evidence checked: September 2026.